Innoviva, Inc.

Innoviva, Inc. (ticker: INVA) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of INVA's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. INVA reported $97.99M in revenue and $4.43M for the period ending 2026-03-31, with operating cash flow of $35.28M. Cash and equivalents stood at $603.09M (up 89% year-over-year). Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.